179 related articles for article (PubMed ID: 15302139)
1. Intracellular metabolism and pharmacokinetics of 5'-hydrogenphosphonate of 3'-azido-2',3'-dideoxythymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine.
Skoblov Y; Karpenko I; Shirokova E; Popov K; Andronova V; Galegov G; Kukhanova M
Antiviral Res; 2004 Aug; 63(2):107-13. PubMed ID: 15302139
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
[TBL] [Abstract][Full Text] [Related]
3. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine).
Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C
Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
Quevedo MA; Briñón MC
Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice.
Tan X; Boudinot FD; Chu CK; Egron D; Perigaud C; Gosselin G; Imbach JL
Antivir Chem Chemother; 2000 May; 11(3):203-11. PubMed ID: 10901291
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice.
Parang K; Wiebe LI; Knaus EE
J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159
[TBL] [Abstract][Full Text] [Related]
7. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion.
Patterson TA; Binienda ZK; Lipe GW; Gillam MP; Slikker W; Sandberg JA
Drug Metab Dispos; 1997 Apr; 25(4):453-9. PubMed ID: 9107545
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine).
Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E
ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623
[TBL] [Abstract][Full Text] [Related]
9. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP.
Ostermann N; Lavie A; Padiyar S; Brundiers R; Veit T; Reinstein J; Goody RS; Konrad M; Schlichting I
J Mol Biol; 2000 Nov; 304(1):43-53. PubMed ID: 11071809
[TBL] [Abstract][Full Text] [Related]
10. A method for quantitating the intracellular metabolism of AZT amino acid phosphoramidate pronucleotides by capillary high-performance liquid chromatography-electrospray ionization mass spectrometry.
Kim J; Park S; Tretyakova NY; Wagner CR
Mol Pharm; 2005; 2(3):233-41. PubMed ID: 15934784
[TBL] [Abstract][Full Text] [Related]
11. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
[TBL] [Abstract][Full Text] [Related]
12. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
[TBL] [Abstract][Full Text] [Related]
13. Decomposition of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate (AZTMP) prodrugs in biological media studied by on-line solid-phase extraction coupled to liquid chromatography mass spectrometry.
Lefebvre I; Beltran T; Peyrottes S; Périgaud C
Biomed Chromatogr; 2009 Nov; 23(11):1160-8. PubMed ID: 19444806
[TBL] [Abstract][Full Text] [Related]
14. Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate.
Song H; Johns R; Griesgraber GW; Wagner CR; Zimmerman CL
Pharm Res; 2003 Mar; 20(3):448-51. PubMed ID: 12669967
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE
Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
[TBL] [Abstract][Full Text] [Related]
16. [Adducts of 3'-azido-2,3'-dideoxythymidine 5'-phosphate or 5'-phosphonate as inhibitors of cytopathic effect and transformation of cells under the influence of retroviruses in cell culture].
Fedorov II; Kraevskiĭ AA; Bal'zarinin Zh; De Klerk E
Mol Biol (Mosk); 1992; 26(5):1122-7. PubMed ID: 1470177
[TBL] [Abstract][Full Text] [Related]
17. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
Zhu Z; Schinazi RF; Chu CK; Williams GJ; Colby CB; Sommadossi JP
Mol Pharmacol; 1990 Dec; 38(6):929-38. PubMed ID: 2250666
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled drug delivery systems. Part 4. In vitro/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine.
Jin Y; Xing L; Tian Y; Li M; Gao C; Du L; Dong J; Chen H
Int J Pharm; 2009 Oct; 381(1):40-8. PubMed ID: 19646518
[TBL] [Abstract][Full Text] [Related]
19. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacokinetic features and metabolism of the novel cytotoxic nucleoside analog 3'-azidothymidine 5'-[p-methoxyphenyl methoxyalaninyl phosphate] (Compound 003).
Uckun FM; Chen CL; Liu XP; Dibirdik I; Venkatachalam TK
Arzneimittelforschung; 2004; 54(11):732-45. PubMed ID: 15612614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
